Recent Quarter Total Invested
$1.36 B
Recent Quarter Institutional Ownership Percentage
118.38%
Total Invested of Last Quarter
$718.57 M
Ownership Percentage of Last Quarter
89.06%
Nurix Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 174,393 | $3.64 M | 100.00% | 0.32% |
| JANE STREET GROUP, LLC | 08/15/2024 | 200,097 | $4.18 M | 252.82% | 0.36% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 203,273 | $4.24 M | 100.00% | 0.37% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 209,136 | $4.36 M | 31.35% | 0.38% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 221,327 | $4.62 M | 127.76% | 0.40% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 224,908 | $4.69 M | -48.23% | 0.41% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 238,582 | $4.98 M | 12.07% | 0.43% |
| WESTHILL FINANCIAL ADVISORS, INC. | 07/19/2024 | 283,333 | $5.91 M | 0.00% | 0.52% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/09/2024 | 290,000 | $6.05 M | 3.94% | 0.53% |
| WOODLINE PARTNERS LP | 08/14/2024 | 301,887 | $6.30 M | 100.00% | 0.55% |
| BESSEMER GROUP INC | 08/13/2024 | 306,003 | $6.39 M | -14.35% | 0.56% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2024 | 314,762 | $6.57 M | 0.00% | 0.57% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 320,552 | $6.69 M | 93.57% | 0.58% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 324,000 | $6.76 M | 80.70% | 0.59% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 334,972 | $6.99 M | 100.00% | 0.61% |
| INVESCO LTD. | 08/13/2024 | 365,298 | $7.62 M | 16.74% | 0.67% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 418,928 | $8.74 M | 56.78% | 0.76% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 432,289 | $9.02 M | 64.89% | 0.79% |
| NORTHERN TRUST CORP | 08/14/2024 | 438,089 | $9.14 M | 8.44% | 0.80% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 440,500 | $9.19 M | 46.83% | 0.80% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 464,507 | $9.69 M | -5.72% | 0.85% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 474,679 | $9.91 M | 89.87% | 0.86% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 500,000 | $10.44 M | 100.00% | 0.91% |
| NORGES BANK | 08/14/2024 | 507,536 | $10.59 M | 100.00% | 0.92% |
| SAMLYN CAPITAL, LLC | 08/14/2024 | 583,490 | $12.18 M | 100.00% | 1.06% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 599,623 | $12.51 M | 60.22% | 1.09% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 603,133 | $12.59 M | -37.59% | 1.10% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 623,404 | $13.01 M | -2.93% | 1.14% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 650,000 | $13.57 M | 100.00% | 1.18% |
| WASATCH ADVISORS LP | 08/14/2024 | 858,067 | $17.91 M | -30.62% | 1.56% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 912,000 | $19.03 M | 12.56% | 1.66% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 981,167 | $20.48 M | 134.27% | 1.79% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.04 M | $21.72 M | 384.67% | 1.90% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.05 M | $21.88 M | -30.08% | 1.91% |
| CANDRIAM S.C.A. | 08/05/2024 | 1.16 M | $24.30 M | 30.50% | 2.12% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 1.17 M | $24.49 M | 61.43% | 2.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 1.28 M | $26.78 M | 100.00% | 2.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.32 M | $27.59 M | 20.12% | 2.41% |
| MORGAN STANLEY | 08/14/2024 | 1.99 M | $41.53 M | -21.38% | 3.62% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 2.06 M | $42.91 M | 84.39% | 3.74% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 2.19 M | $45.69 M | 100.00% | 3.99% |
| ARK INVESTMENT MANAGEMENT LLC | 07/26/2024 | 2.32 M | $48.49 M | -11.84% | 4.23% |
| STATE STREET CORP | 08/14/2024 | 2.71 M | $56.53 M | -0.76% | 4.93% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.84 M | $59.17 M | 29.09% | 5.16% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 3.20 M | $66.82 M | 1,273.39% | 5.83% |
| VANGUARD GROUP INC | 08/13/2024 | 3.63 M | $75.65 M | 40.27% | 6.60% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 3.88 M | $81.02 M | 0.00% | 7.07% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 3.99 M | $83.30 M | 33.15% | 7.27% |
| REDMILE GROUP, LLC | 08/14/2024 | 4.42 M | $92.32 M | -1.33% | 8.06% |
| BLACKROCK INC. | 08/13/2024 | 6.82 M | $142.33 M | 48.90% | 12.42% |
Nurix Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NRIX shares?
During the previous two years, 200 institutional investors and hedge funds held shares of Nurix Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 6.82 M
Redmile Group, LLC: 4.42 M
Deep Track Capital, LP: 3.99 M
BAKER BROS. ADVISORS LP: 3.88 M
VANGUARD GROUP INC: 3.63 M
WELLINGTON MANAGEMENT GROUP LLP: 3.2 M
-
What percentage of Nurix Therapeutics, Inc. stock is owned by institutional investors?
118.38% of Nurix Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at NRIX ?
Institutional investors have bought a total of 74.00 M shares in the last 24 months. This purchase volume represents approximately $1.64 B in transactions.